Macrogenics reported $41.73M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US USD 14.81B 229M
Amgen AMGN:US USD 6.84B 187M
AstraZeneca AZN:LN USD 10.98B 211M
Biogen BIIB:US USD 2.51B 80.6M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Daiichi Sankyo 4568:JP JPY 340.48B 13B
Eli Lilly And LLY:US USD 7.3B 360.2M
Genmab GEN:DC DKK 4.09B 925M
Geron GERN:US USD 297K 224K
Gilead Sciences GILD:US USD 7.39B 347M
Immunogen IMGN:US USD 15.38M 1.21M
Johnson & Johnson JNJ:US USD 23.71B 85M
Karyopharm Therapeutics KPTI:US USD 36.14M 3.53M
Macrogenics MGNX:US USD 41.73M 15.73M
Merk MRK:US USD 13.83B 1.13B
Mirati Therapeutics MRTX:US USD 5.43M 69K
Pfizer PFE:US USD 24.29B 1.65B
Puma Biotechnology PBYI:US USD 57.1M 2.42M
Regeneron Pharmaceuticals REGN:US USD 3.41B 478.2M
Roche Holding ROG:VX CHF 32.3B 207M
Seattle Genetics SGEN:US USD 510.3M 12.8M
Xencor XNCR:US USD 27.3M 2.88M